Biosimilar
Bora Pharmaceuticals Acquires 30.5% Stake in Tanvex Biopharma, Becomes Largest Corporate Shareholder
2024-08-28
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28